The global lupus therapeutics market is expected to grow from USD 1.87 billion in 2020 to USD 3.62 billion by 2028, at a CAGR of 6.2% during the forecast period 2021-2028.
Lupus therapeutics is a kind of therapy used to treat lupus disease (also called SLE, systemic lupus erythematosus). Lupus is a chronic autoimmune disease in which the body’s own immune system starts attacking healthy tissues by becoming hyperactive. Some of the symptoms of Lupus include swelling, rash, fever, inflammation, and damage to the skin, joints, kidneys, heart, lungs, and blood cells. The primary driver of the global lupus therapeutics market is the introduction of plenty, new therapies by biopharmaceutical companies and the rise in patient numbers towards biologics because of the enhanced efficacy of the novel therapies.
This study delivers a comprehensive analysis of drug classes, route of administration, and regions. The research includes growth drivers as well as challenges prevalent in the global lupus therapeutics market, along with the impact they will have on the overall demand during the forecasted period. Additionally, the study also includes various opportunities & threats that are present in the lupus therapeutics market.Based on drug classes, the global market has been divided into immunosuppressants, corticosteroids, NSAIDs, antimalarials, and biologics. The immunosuppressants segment held the largest market share of 28.65% in 2020, primarily due to the global prevalence of methotrexate, a low-cost immunosuppressant. The biologics segment held the second largest market share because of the slow penetrating Benlysta biologic.On the basis of route of administration, the lupus therapeutics market has been segmented into subcutaneous, oral, and intravenous. The subcutaneous segment is anticipated to grow at the highest CAGR of 6.9% over the projected period owing to its self-administration capabilities and its (Rituximab) approval in many European countries and & the United States.
The market has been divided into North America, Europe, Asia-Pacific, Middle East & Africa, and South America. With the rapid development of medical technology and improving economic conditions, the Asia-Pacific region stands as a promising market for lupus therapeutics and is expected to grow at the highest CAGR during the forecast period.
Some of the notable players in the lupus therapeutics market are Hikma Pharmaceuticals Plc, Dr. Reddy’s Laboratories Ltd, GlaxoSmithKline, Novartis AG, Sanofi, ImmuPharma, Bayer, Aurinia Pharmaceuticals, Pfizer Inc, Astra Zeneca, MedImmune, F.Hoffmann-La Roche, Bristol Myers Squibb Company, Teva Pharmaceutical Industries Ltd, BoehringerIngelheim International Gmbh, among others. The key players are now concentrating on implementing strategies such as adopting new technology, product innovations, mergers & acquisitions, joint ventures, alliances, and partnerships to improve their market position in the global lupus therapeutics industry.
This study predictsrevenue growth at global, national, and country levels from 2021 to 2028. Fior Markets has segmented the market based on the below-mentioned segments:
Global Lupus Therapeutics Market Analysis and Forecast, By Drug Classes
Global Lupus Therapeutics Market Analysis and Forecast, By Route of Administration
Global Lupus Therapeutics Market Analysis and Forecast, By Regional Analysis
Report Description:
1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Research Scope
1.4. Currency
1.5. Key Target Audience
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
4.1. Porter’s Five Forces Analysis
4.2. Value Chain Analysis
4.3. Top Investment Pockets
4.3.1. Market Attractiveness Analysis By Drug Classes
4.3.2. Market Attractiveness Analysis By Route of Administration
4.3.3. Market Attractiveness Analysis By Region
4.4. Industry Trends
5. Market Dynamics
5.1. Market Evaluation
5.2. Drivers
5.2.1. New launches of key pipeline agents with greater efficacy
5.3. Restraints
5.3.1. Slow regulatory approvals
5.4. Opportunities
5.4.1. New drug development
6. Global Lupus Therapeutics Market Analysis and Forecast, By Drug Classes
6.1. Segment Overview
6.2. Immunosuppressants
6.3. Corticosteroids
6.4. NSAIDs
6.5. Antimalarials
6.6. Biologics
7. Global Lupus Therapeutics Market Analysis and Forecast, By Route of Administration
7.1. Segment Overview
7.2. Subcutaneous
7.3. Oral
7.4. Intravenous
8. Global Lupus Therapeutics Market Analysis and Forecast, By Regional Analysis
8.1. Segment Overview
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.4. Asia-Pacific
8.4.1. Japan
8.4.2. China
8.4.3. India
8.5. South America
8.5.1. Brazil
8.6. Middle East and Africa
8.6.1. UAE
8.6.2. South Africa
9. Global Lupus Therapeutics Market-Competitive Landscape
9.1. Overview
9.2. Market Share of Key Players in Global Lupus Therapeutics Market
9.2.1. Global Company Market Share
9.2.2. North America Company Market Share
9.2.3. Europe Company Market Share
9.2.4. APAC Company Market Share
9.3. Competitive Situations and Trends
9.3.1. Products, Launches and Developments
9.3.2. Partnerships, Collaborations, and Agreements
9.3.3. Mergers & Acquisitions
9.3.4. Expansions
10. Company Profiles
10.1. Hikma Pharmaceuticals Plc
10.1.1. Business Overview
10.1.2. Company Snapshot
10.1.3. Company Market Share Analysis
10.1.4. Company Product Portfolio
10.1.5. Recent Developments
10.1.6. SWOT Analysis
10.2. Dr. Reddy’s Laboratories Ltd.
10.2.1. Business Overview
10.2.2. Company Snapshot
10.2.3. Company Market Share Analysis
10.2.4. Company Product Portfolio
10.2.5. Recent Developments
10.2.6. SWOT Analysis
10.3. GlaxoSmithKline
10.3.1. Business Overview
10.3.2. Company Snapshot
10.3.3. Company Market Share Analysis
10.3.4. Company Product Portfolio
10.3.5. Recent Developments
10.3.6. SWOT Analysis
10.4. Novartis AG
10.4.1. Business Overview
10.4.2. Company Snapshot
10.4.3. Company Market Share Analysis
10.4.4. Company Product Portfolio
10.4.5. Recent Developments
10.4.6. SWOT Analysis
10.5. Sanofi
10.5.1. Business Overview
10.5.2. Company Snapshot
10.5.3. Company Market Share Analysis
10.5.4. Company Product Portfolio
10.5.5. Recent Developments
10.5.6. SWOT Analysis
10.6. ImmuPharma
10.6.1. Business Overview
10.6.2. Company Snapshot
10.6.3. Company Market Share Analysis
10.6.4. Company Product Portfolio
10.6.5. Recent Developments
10.6.6. SWOT Analysis
10.7. Bayer
10.7.1. Business Overview
10.7.2. Company Snapshot
10.7.3. Company Market Share Analysis
10.7.4. Company Product Portfolio
10.7.5. Recent Developments
10.7.6. SWOT Analysis
10.8. Aurinia Pharmaceuticals
10.8.1. Business Overview
10.8.2. Company Snapshot
10.8.3. Company Market Share Analysis
10.8.4. Company Product Portfolio
10.8.5. Recent Developments
10.8.6. SWOT Analysis
10.9. Pfizer Inc
10.9.1. Business Overview
10.9.2. Company Snapshot
10.9.3. Company Market Share Analysis
10.9.4. Company Product Portfolio
10.9.5. Recent Developments
10.9.6. SWOT Analysis
10.10. Astra Zeneca
10.10.1. Business Overview
10.10.2. Company Snapshot
10.10.3. Company Market Share Analysis
10.10.4. Company Product Portfolio
10.10.5. Recent Developments
10.10.6. SWOT Analysis
10.11. MedImmune
10.11.1. Business Overview
10.11.2. Company Snapshot
10.11.3. Company Market Share Analysis
10.11.4. Company Product Portfolio
10.11.5. Recent Developments
10.11.6. SWOT Analysis
10.12. F.Hoffmann-La Roche
10.12.1. Business Overview
10.12.2. Company Snapshot
10.12.3. Company Market Share Analysis
10.12.4. Company Product Portfolio
10.12.5. Recent Developments
10.12.6. SWOT Analysis
10.13. Bristol Myers Squibb Company
10.13.1. Business Overview
10.13.2. Company Snapshot
10.13.3. Company Market Share Analysis
10.13.4. Company Product Portfolio
10.13.5. Recent Developments
10.13.6. SWOT Analysis
10.14. Teva Pharmaceutical Industries Ltd
10.14.1. Business Overview
10.14.2. Company Snapshot
10.14.3. Company Market Share Analysis
10.14.4. Company Product Portfolio
10.14.5. Recent Developments
10.14.6. SWOT Analysis
10.15. BoehringerIngelheim International Gmbh
10.15.1. Business Overview
10.15.2. Company Snapshot
10.15.3. Company Market Share Analysis
10.15.4. Company Product Portfolio
10.15.5. Recent Developments
10.15.6. SWOT Analysis
List of Table
1. Global Lupus Therapeutics Market, By Drug Classes, 2020-2028(USD Billion)
2. Global Immunosuppressants, Lupus Therapeutics Market, By Region, 2020-2028(USD Billion)
3. GlobalCorticosteroids, Lupus Therapeutics Market, By Region, 2020-2028(USD Billion)
4. Global NSAIDs, Lupus Therapeutics Market, By Region, 2020-2028(USD Billion)
5. Global Antimalarials, Lupus Therapeutics Market, By Region, 2020-2028(USD Billion)
6. Global Biologics, Lupus Therapeutics Market, By Region, 2020-2028(USD Billion)
7. Global Lupus Therapeutics Market, ByRoute of Administration, 2020-2028(USD Billion)
8. GlobalSubcutaneous, Lupus Therapeutics Market, By Region, 2020-2028(USD Billion)
9. Global Oral, Lupus Therapeutics Market, By Region, 2020-2028(USD Billion)
10. Global Intravenous, Lupus Therapeutics Market, By Region, 2020-2028(USD Billion)
11. North America Lupus Therapeutics Market, By Drug Classes, 2020-2028(USD Billion)
12. North America Lupus Therapeutics Market, ByRoute of Administration, 2020-2028(USD Billion)
13. U.S. Lupus Therapeutics Market, By Drug Classes, 2020-2028(USD Billion)
14. U.S. Lupus Therapeutics Market, By Route of Administration, 2020-2028(USD Billion)
15. Canada Lupus Therapeutics Market, By Drug Classes, 2020-2028(USD Billion)
16. Canada Lupus Therapeutics Market, By Route of Administration, 2020-2028(USD Billion)
17. Mexico Lupus Therapeutics Market, By Drug Classes, 2020-2028(USD Billion)
18. Mexico Lupus Therapeutics Market, By Route of Administration, 2020-2028(USD Billion)
19. Europe Lupus Therapeutics Market, By Drug Classes, 2020-2028(USD Billion)
20. Europe Lupus Therapeutics Market, By Route of Administration, 2020-2028(USD Billion)
21. Germany Lupus Therapeutics Market, By Drug Classes, 2020-2028(USD Billion)
22. Germany Lupus Therapeutics Market, By Route of Administration, 2020-2028(USD Billion)
23. France Lupus Therapeutics Market, By Drug Classes, 2020-2028(USD Billion)
24. France Lupus Therapeutics Market, By Route of Administration, 2020-2028(USD Billion)
25. U.K. Lupus Therapeutics Market, By Drug Classes, 2020-2028(USD Billion)
26. U.K. Lupus Therapeutics Market, By Route of Administration, 2020-2028(USD Billion)
27. Italy Lupus Therapeutics Market, By Drug Classes, 2020-2028(USD Billion)
28. Italy Lupus Therapeutics Market, By Route of Administration, 2020-2028(USD Billion)
29. Spain Lupus Therapeutics Market, By Drug Classes, 2020-2028(USD Billion)
30. Spain Lupus Therapeutics Market, By Route of Administration, 2020-2028(USD Billion)
31. Asia Pacific Lupus Therapeutics Market, By Drug Classes, 2020-2028(USD Billion)
32. Asia Pacific Lupus Therapeutics Market, By Route of Administration, 2020-2028(USD Billion)
33. Japan Lupus Therapeutics Market, By Drug Classes, 2020-2028(USD Billion)
34. Japan Lupus Therapeutics Market, By Route of Administration, 2020-2028(USD Billion)
35. China Lupus Therapeutics Market, By Drug Classes, 2020-2028(USD Billion)
36. China Lupus Therapeutics Market, By Route of Administration, 2020-2028(USD Billion)
37. India Lupus Therapeutics Market, By Drug Classes, 2020-2028(USD Billion)
38. India Lupus Therapeutics Market, By Route of Administration, 2020-2028(USD Billion)
39. South America Lupus Therapeutics Market, By Drug Classes, 2020-2028(USD Billion)
40. South America Lupus Therapeutics Market, By Route of Administration, 2020-2028(USD Billion)
41. Brazil Lupus Therapeutics Market, By Drug Classes, 2020-2028(USD Billion)
42. Brazil Lupus Therapeutics Market, By Route of Administration, 2020-2028(USD Billion)
43. Middle East and Africa Lupus Therapeutics Market, By Drug Classes, 2020-2028(USD Billion)
44. Middle East and Africa Lupus Therapeutics Market, By Route of Administration, 2020-2028(USD Billion)
45. UAE Lupus TherapeuticsMarket, By Drug Classes, 2020-2028(USD Billion)
46. UAE Lupus Therapeutics Market, By Route of Administration, 2020-2028(USD Billion)
47. South Africa Lupus Therapeutics Market, By Drug Classes, 2020-2028(USD Billion)
48. South Africa Lupus Therapeutics Market, By Route of Administration, 2020-2028(USD Billion)
List of Figures
1. Global Lupus Therapeutics Market Segmentation
2. Global Lupus Therapeutics Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Lupus Therapeutics Market Attractiveness Analysis By Drug Classes
9. Global Lupus Therapeutics Market Attractiveness Analysis By Route of Administration
10. Global Lupus Therapeutics Market Attractiveness Analysis By Region
11. Global Lupus Therapeutics Market: Dynamics
12. Global Lupus Therapeutics Market Share by Drug Classes (2020 &2028)
13. Global Lupus Therapeutics Market Share by Route of Administration (2020 &2028)
14. Global Lupus Therapeutics Market Share by Regions (2020 &2028)
15. Global Lupus Therapeutics Market Share by Company (2020)
Market research is a method of gathering, assessing and deducing data & information about a particular market. Market research is very crucial in these days. The techniques analyze about how a product/service can be offered to the market to its end-customers, observe the impact of that product/service based on the past customer experiences, and cater their needs and demands. Owing to the successful business ventures, accurate, relevant and thorough information is the base for all the organizations because market research report/study offers specific market related data & information about the industry growth prospects, perspective of the existing customers, and the overall market scenario prevailed in past, ongoing present and developing future. It allows the stakeholders and investors to determine the probability of a business before committing substantial resources to the venture. Market research helps in solving the marketing issues challenges that a business will most likely face.
Market research is valuable because of the following reasons:
Our research report features both the aspects; qualitative and quantitative. Qualitative part provides insights about the market driving forces, potential opportunities, customer’s demands and requirement which in turn help the companies to come up with new strategies in order to survive in the long run competition. The quantitative segment offers the most credible information related to the industry. Based on the data gathering, we use to derive the market size and estimate their future growth prospects on the basis of global, region and country.
Our market research process involves with the four specific stages.
Data Collection: This stage of the market research process involves with the gathering and collecting of the market/industry related data from the sources. There are basically two types of research methods:
Data Synthesis: This stage includes the evaluation and assessment of all the data acquired from the primary and secondary research. It likewise includes in evaluating the information for any disparity watched while information gathering identified with the market. The data & information is gathered with consideration to the heterogeneity of sources. Scientific and statistical methods are implemented for synthesizing dissimilar information sets and provide the relevant data which is fundamental for formulating strategies. Our organization has broad involvement with information amalgamation where the information goes through different stages:
Market Formulation & Deduction: The last stage includes assigning the data & information in a suitable way in order to derive market size. Analyst reviews and domain based opinions based on holistic approach of market estimation combined with industry investigation additionally features a crucial role in this stage.
This stage includes with the finalization of the market size and numbers that we have gathered from primary and secondary research. With the data & information addition, we ensure that there is no gap in the market information. Market trend analysis is finished by our analysts by utilizing data extrapolation procedures, which give the most ideal figures to the market.
Data Validation: Validation is the most crucial step in the process. Validation & re-validation through scientifically designed technique and process that helps us finalize data-points to be used for final calculations. This stage also involves with the data triangulation process. Data triangulation generally implicates the cross validation and matching the data which has been collected from primary and secondary research methods.
Free Customization
Countries can be added on demand
Free yearly update on purchase of Multi/Corporate User License
Companies served till date
We serve our customers 24x7 for 365 days through calls, emails and live chat options.
Huge database of exceptional market reports bringing market intelligence to your fingertips.
SSL enabled, we offer you various secured payment options for risk free purchase.